Literature DB >> 7150424

Basal kinetic studies of Tc-99m DMPE as a myocardial imaging agent in the dog.

H Nishiyama, E Deutsch, R J Adolph, V J Sodd, K Libson, E L Saenger, M C Gerson, M Gabel, S J Lukes, J L Vanderheyden, D L Fortman, K L Scholz, L W Grossman, C C Williams.   

Abstract

Newly synthesized Tc-99m dichlorobis(1,2-dimethylphosphino)ethane (DMPE) was investigated as a myocardial imaging agent with respect to its kinetics (dependent on both time and regional coronary blood flow), its percent organ uptake, and its imaging characteristics in the anesthetized dog. Most of these data are compared with those of Tl-201. Blood clearance of the two agents is essentially the same. Compared with Tl-201, Tc-99m DMPE shows faster overall kinetics, higher heart-to-lung ratio, equally good correlation with a wide range of regional blood flows, and higher liver uptake. At the time of peak myocardial uptake, the mean heart uptake of Tl-201 is 4.3%, compared with 2.9% for Tc-99m DMPE, yet only 0.9% uptake of Tc-99m DMPE is found in the lung as compared with 3.3% for Tl-201. These differences result in a heart-to-lung ratio of 2:1 for Tc-99m DMPE and 1:1 for Tl-201, based on the data obtained from the time-activity curve. The quantitative findings are supported by the superior quality of Tc-99m DMPE images of both normal and infarcted dog heart. The high hepatic uptake of Tc-99m DMPE is not a serious problem if images are obtained within 5-60 min after dose. These basic kinetic studies suggest that Tc-99m DMPE is a promising myocardial imaging agent.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150424

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  The utilization of Tc-99m-TBI as a myocardial perfusion agent in exercise studies: comparison with Tl-201 thallous chloride and examination of its biodistribution in humans.

Authors:  S T Sia; B L Holman; K McKusick; P Rigo; F Gillis; V Sporn; N Perez-Balino; A Mitta; H Vosberg; Z Szabo
Journal:  Eur J Nucl Med       Date:  1986

2.  99mTc-sestamibi can improve the inferior attenuation of TL-201 myocardial spect imaging.

Authors:  S J Wang; Y T Chen; C L Hwang; M S Lin; C H Kao; S H Yeh
Journal:  Int J Card Imaging       Date:  1993-06

3.  Myocardial perfusion imaging with 99mTc-methoxy-isobutyl-isonitrile (MIBI): comparison of short and long time intervals between rest and stress injections. Preliminary results.

Authors:  R Taillefer; L Laflamme; G Dupras; M Picard; D C Phaneuf; J Léveillé
Journal:  Eur J Nucl Med       Date:  1988

4.  Evaluation of 99mTc-dichloro bis (1,2-dimethylphosphino) ethane (99mTc-DMPE) for myocardial scintigraphy in man.

Authors:  R Dudczak; P Angelberger; R Homan; K Kletter; R Schmoliner; H Frischauf
Journal:  Eur J Nucl Med       Date:  1983

5.  Myocardial perfusion imaging with 99mTc-DMPE in man.

Authors:  M C Gerson; E A Deutsch; H Nishiyama; K F Libson; R J Adolph; L W Grossman; V J Sodd; D L Fortman; J L Vanderheyden; C C Williams
Journal:  Eur J Nucl Med       Date:  1983

6.  Clinical comparison between thallium-201 and Tc-99m-methoxy isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease.

Authors:  R Taillefer; R Lambert; G Dupras; J Grégoire; J Léveillé; R Essiambre; D C Phaneuf
Journal:  Eur J Nucl Med       Date:  1989
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.